COPD Clinical Trials near Birmingham, AL
16 studies for COPD are recruiting at 16 sites within 50 miles of Birmingham, Alabama, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all COPD trials in the US or all trials near Birmingham.
Recruiting now
COPD studies enrolling near Birmingham
- SPIROMICS Study of Early COPD Progression (SOURCE)
NCT05033990
- Observational
- Ages 30 to 55 years
- Sex: All
- Accepts healthy volunteers
Nearest site: University of Alabama at Birmingham (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
NCT05204888
- Interventional
- Ages 30 years and older
- Sex: All
Nearest site: UAB School of Medicine/Lung Health Center (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Multi-Center Clean Air Randomized Controlled Trial in COPD
NCT06376994
- Phase 3
- Ages 40 years and older
- Sex: All
Nearest site: University of Alabama, Lung Health Center (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
NCT06603246
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: University of Alabama at Birmingham (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
NCT06891755
- Interventional
- Ages 40 to 84 years
- Sex: All
Nearest site: University of Alabama at Birmingham (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
NCT07051707
- Interventional
- Ages 40 to 80 years
- Sex: All
Nearest site: University of Alabama-Birmingham Hospital - UAB Lung Health Center (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
NCT07053423
- Phase 4
- Ages 40 to 85 years
- Sex: All
Nearest site: University of Alabama at Birmingham - School of Medicine- Site Number : 8400003 (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest site: Research Site (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
NCT07135427
- Phase 4
- Ages 19 years and older
- Sex: All
Nearest site: University of Alabama at Birmingham (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: University of Alabama at Birmingham- Site Number : 8400003 (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
NCT07222410
- Interventional
- Ages 22 years and older
- Sex: All
Nearest site: The University of Alabama at Birmingham (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694
- Phase 2/3
- Ages 35 to 80 years
- Sex: All
Nearest site: University of Alabama at Birmingham Lung Health Center (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
NCT07748858
- Observational
- Ages 50 to 99 years
- Sex: All
Nearest site: Cooper Green Mercy Hospital (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245
- Phase 2
- Ages 40 to 75 years
- Sex: All
Nearest site: University of Alabama at Birmingham (Birmingham, AL)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Research Site (Cullman, AL)
- Distance to nearest recruiting site
- ~45 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: Research Site (Cullman, AL)
- Distance to nearest recruiting site
- ~45 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a COPD clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.